1 |
Baclofen
| 2件: Baclofen Baclofen; Kemstro | 1件: D00241
D00241
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 7件: 2 2, 10, 13, 18, 65, 149, 206 |
2 |
Balsalazide
| 3件: 2-Hydroxybenzoic acid 2-Hydroxybenzoic acid; Balsalazide; Balsalazide Disodium | 2件: D02715
D02715
,
D07488
| - | - | 1件: 97 97 |
3 |
Baminercept
| 2件: Baminercept Baminercept; Baminercept alfa | 1件: D08866
D08866
| 1件: LTB LTB 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 4件: 13 13, 46, 53, 97 |
4 |
Bardoxolone
| 1件: Bardoxolone Bardoxolone | 1件: D09584
D09584
| - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 |
5 |
Bardoxolone methyl
| 1件: Bardoxolone methyl Bardoxolone methyl | 1件: D09585
D09585
| - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 |
6 |
Baricitinib
| 2件: Baricitinib Baricitinib; Olumiant | 1件: D10308
D10308
| 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 13件: 41 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325 |
7 |
Barium
| 1件: Barium Barium | - | - | - | 3件: 2 2, 19, 98 |
8 |
Basic Fibroblast Growth Factor
| 1件: BFGF BFGF | - | - | - | 1件: 56 56 |
9 |
Basiliximab
| 2件: Basiliximab Basiliximab; Simulect | 1件: D03058
D03058
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 6件: 2 2, 50, 66, 97, 222, 228 |
10 |
Basimglurant
| 1件: Basimglurant Basimglurant | 1件: D10864
D10864
| - | - | 1件: 158 158 |
11 |
Bavisant
| 1件: Bavisant Bavisant | 1件: D09870
D09870
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
12 |
Bazedoxifene
| 1件: Bazedoxifene Bazedoxifene | - | - | - | 1件: 13 13 |
13 |
BCG vaccine
| 0件: | 1件: D03063
D03063
| - | - | 1件: 299 299 |
14 |
Bean
| 1件: Bean Bean | - | - | - | 1件: 96 96 |
15 |
Beclomethasone dipropionate
| 2件: BECLOMETASONE DIPROPIONATE BECLOMETASONE DIPROPIONATE; Beclomethasone dipropionate | 2件: D00689
D00689
,
D07495
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 85 85, 97, 98 |
16 |
Begelomab
| 1件: Begelomab Begelomab | - | - | - | 1件: 50 50 |
17 |
Belantamab mafodotin
| 1件: Belantamab mafodotin Belantamab mafodotin | 1件: D11595
D11595
| 10件: TNFRSF17 TNFRSF17, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 12件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 28 28 |
18 |
Belatacept
| 2件: Belatacept Belatacept; Nulojix | 1件: D03222
D03222
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
19 |
Belimumab
| 2件: Belimumab Belimumab; BENLYSTA | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 12件: 11 11, 13, 43, 44, 46, 49, 51, 53, 66, 222, 296, 300 |
20 |
Beloranib
| 1件: Beloranib Beloranib | - | - | - | 1件: 193 193 |
21 |
Belumosudil
| 1件: Belumosudil Belumosudil | 1件: D11815
D11815
| 1件: ROCK2 ROCK2 💬 | 21件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 |
22 |
Benazepril
| 1件: Benazepril Benazepril | 2件: D00620
D00620
,
D07499
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 4件: 49 49, 57, 218, 224 |
23 |
Bendamustine
| 2件: Bendamustine Bendamustine; BENDAMUSTINE HYDROCHLORIDE | 1件: D07501
D07501
| - | - | 2件: 28 28, 61 |
24 |
Bendroflumethiazide
| 1件: BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE | 1件: D00650
D00650
| 1件: SLC12A3 SLC12A3 💬 | - | 1件: 67 67 |
25 |
Benralizumab
| 2件: Benralizumab Benralizumab; Fasenra | 1件: D09874
D09874
| 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
26 |
Benserazide
| 1件: BENSERAZIDE BENSERAZIDE | 1件: D03082
D03082
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
27 |
Bentiromide
| 0件: | 1件: D01346
D01346
| - | - | 6件: 51 51, 89, 113, 117, 298, 299 |
28 |
Benzbromarone
| 1件: BENZBROMARONE BENZBROMARONE | 1件: D01056
D01056
| 1件: SLC22A12 SLC22A12 💬 | - | 1件: 86 86 |
29 |
Benzimidazole
| 1件: Benzimidazole Benzimidazole | - | - | - | 1件: 46 46 |
30 |
Benznidazole
| 1件: Benznidazole Benznidazole | 1件: D02489
D02489
| - | - | 1件: 65 65 |
31 |
Benzofuran
| 1件: Benzofuran Benzofuran | - | - | - | 1件: 6 6 |
32 |
Benzoic acid
| 1件: Benzoic acid Benzoic acid | 1件: D00038
D00038
| - | - | 1件: 51 51 |
33 |
Benzylpenicillin
| 0件: | 3件: D01053
D01053
,
D02157
,
D02336
| - | - | 1件: 46 46 |
34 |
Beraprost
| 1件: Beraprost Beraprost | 1件: D02720
D02720
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
35 |
Berberine
| 1件: Berberine Berberine | - | - | - | 2件: 97 97, 265 |
36 |
Bermekimab
| 1件: BERMEKIMAB BERMEKIMAB | 1件: D11253
D11253
| 1件: IL1A IL1A 💬 | 21件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 51 51 |
37 |
Beroctocog alfa
| 4件: Alphanate Alphanate; Factor VIII; Humate-P; Octanate | - | - | - | 1件: 288 288 |
38 |
Beta carotene
| 3件: Beta carotene Beta carotene; Beta-Carotene; BETACAROTENE | 1件: D03101
D03101
| - | - | 2件: 13 13, 96 |
39 |
beta-Alanine
| 1件: Beta-Alanine Beta-Alanine | 1件: D07561
D07561
| - | - | 1件: 13 13 |
40 |
beta-Sitosterol
| 1件: Sitosterol Sitosterol | 1件: D08518
D08518
| - | - | 1件: 260 260 |
41 |
Betadex
| 1件: Beta-cyclodextrin Beta-cyclodextrin | 1件: D02401
D02401
| - | - | 1件: 19 19 |
42 |
Betaine
| 1件: Betaine Betaine | 1件: D07523
D07523
| - | - | 2件: 201 201, 337 |
43 |
Betamethasone
| 1件: Betamethasone Betamethasone | 7件: D00244
D00244
,
D00972
,
D01357
,
D01402
,
D01637
,
D02032
,
D02286
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
44 |
Bethanechol
| 1件: Bethanechol Bethanechol | 1件: D01000
D01000
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 98 98 |
45 |
Betulinic Acid
| 1件: Episalvan Episalvan | - | - | - | 1件: 36 36 |
46 |
Bevacizumab
| 2件: AVASTIN AVASTIN; Bevacizumab | 1件: D06409
D06409
| 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 9件: 13 13, 34, 85, 86, 87, 89, 227, 280, 331 |
47 |
Bevacizumab zirconium Zr-89
| 2件: 89ZR-BEVACIZUMAB 89ZR-BEVACIZUMAB; BEVACIZUMAB ZIRCONIUM ZR-89 | - | - | - | 1件: 34 34 |
48 |
Bevantolol
| 1件: Bevantolol Bevantolol | - | - | - | 1件: 8 8 |
49 |
Bevifimod
| 1件: STAPHYLOCOCCAL PROTEIN A STAPHYLOCOCCAL PROTEIN A | - | - | - | 1件: 63 63 |
50 |
Bexarotene
| 2件: Bexarotene Bexarotene; Targretin | 1件: D03106
D03106
| 3件: RXRA RXRA, RXRB, RXRG 💬 | 17件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 2件: 13 13, 75 |
51 |
Bezafibrate
| 1件: Bezafibrate Bezafibrate | 1件: D01366
D01366
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 7件: 20 20, 93, 94, 160, 296, 316, 324 |
52 |
Bezlotoxumab
| 1件: Bezlotoxumab Bezlotoxumab | 1件: D10453
D10453
| - | - | 2件: 96 96, 97 |
53 |
BIA
| 1件: BIA BIA | - | - | - | 2件: 6 6, 86 |
54 |
Bifenthrin
| 1件: CAPTURE CAPTURE | - | - | - | 2件: 6 6, 46 |
55 |
Bifidobacterium breve
| 1件: Bifidobacterium breve Bifidobacterium breve | - | - | - | 1件: 97 97 |
56 |
Bifidobacterium longum infantis
| 1件: Bifidobacterium infantis Bifidobacterium infantis | - | - | - | 2件: 96 96, 97 |
57 |
Bimagrumab
| 1件: Bimagrumab Bimagrumab | 1件: D10620
D10620
| 2件: ACVR2A ACVR2A, ACVR2B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 15 15 |
58 |
Bimekizumab
| 1件: BIMEKIZUMAB BIMEKIZUMAB | 1件: D11550
D11550
| 2件: IL17A IL17A, IL17F 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 3件: 46 46, 97, 271 |
59 |
Binetrakin
| 1件: Interleukin 4 Interleukin 4 | 1件: D03117
D03117
| 1件: IL4 IL4 💬 | 16件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Leishmaniasis, PI3K-Akt signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 46 46 |
60 |
Binimetinib
| 1件: Binimetinib Binimetinib | 1件: D10604
D10604
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 |
61 |
Biomodulin T
| 0件: | - | - | - | 4件: 6 6, 96, 97, 98 |
62 |
Biotin
| 4件: Biotin Biotin; Biotina; D-BIOTIN; Vitamin B7 | 1件: D00029
D00029
| - | - | 5件: 2 2, 8, 10, 13, 20 |
63 |
Birch bark extract
| 2件: BIRCH BARK EXTRACT BIRCH BARK EXTRACT; Episalvan | - | - | - | 1件: 36 36 |
64 |
Birtamimab
| 1件: BIRTAMIMAB BIRTAMIMAB | 1件: D11373
D11373
| - | - | 1件: 28 28 |
65 |
Bisacodyl
| 1件: Bisacodyl Bisacodyl | 1件: D00245
D00245
| - | - | 1件: 13 13 |
66 |
Bisoprolol
| 2件: Bisoprolol Bisoprolol; Bisoprolol Fumarate | 2件: D00634
D00634
,
D02342
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 67 67, 86, 113 |
67 |
Bisphenol A
| 0件: | - | - | - | 1件: 88 88 |
68 |
Blarcamesine
| 1件: Blarcamesine Blarcamesine | 1件: D11383
D11383
| 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬 | 14件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 156 156 |
69 |
Bleomycin
| 1件: Bleomycin Bleomycin | 3件: D02177
D02177
,
D03229
,
D07535
| - | - | 4件: 96 96, 278, 279, 280 |
70 |
Bleselumab
| 1件: Bleselumab Bleselumab | 1件: D11357
D11357
| 1件: CD40 CD40 💬 | 17件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | 1件: 222 222 |
71 |
Blisibimod
| 1件: Blisibimod Blisibimod | 1件: D10311
D10311
| - | - | 5件: 43 43, 44, 49, 63, 66 |
72 |
Bluefish
| 1件: Bluefish Bluefish | - | - | - | 1件: 58 58 |
73 |
BMS-582949
| 1件: BMS-582949 BMS-582949 | - | - | - | 1件: 46 46 |
74 |
BMS-817399
| 1件: BMS-817399 BMS-817399 | - | - | - | 1件: 46 46 |
75 |
BMS-986020
| 1件: BMS-986020 BMS-986020 | - | - | - | 2件: 51 51, 85 |
76 |
BMS-986104
| 1件: BMS-986104 BMS-986104 | - | - | - | 1件: 46 46 |
77 |
BMS-986142
| 1件: BMS-986142 BMS-986142 | - | - | - | 3件: 46 46, 53, 160 |
78 |
Borage oil
| 1件: BORAGE OIL BORAGE OIL | - | - | - | 1件: 13 13 |
79 |
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)
| 3件: Boostrix Boostrix; Filamentous haemagglutinin; Filamentous haemagglutinin adsorbed | - | - | - | 1件: 46 46 |
80 |
Bordetella pertussis pertactin antigen
| 3件: Boostrix Boostrix; Pertactin; Pertactin adsorbed | - | - | - | 1件: 46 46 |
81 |
Bordetella pertussis pertactin antigen (formaldehyde inactivated)
| 1件: Boostrix Boostrix | - | - | - | 1件: 46 46 |
82 |
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
| 2件: Boostrix Boostrix; Pertussis toxoid | - | - | - | 1件: 46 46 |
83 |
Bortezomib
| 3件: Bortezomib Bortezomib; Bortezomib Accord; VELCADE | 1件: D03150
D03150
| 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 16件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331 |
84 |
Bortezomib D-mannitol
| 3件: Bortezomib Bortezomib; Bortezomib D-mannitol; Velcade | - | - | - | 3件: 11 11, 28, 61 |
85 |
Boscalid
| 1件: Endura Endura | - | - | - | 1件: 53 53 |
86 |
Bosentan
| 2件: Bosentan Bosentan; Tracleer | 2件: D01227
D01227
,
D07538
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
87 |
Bosutinib
| 1件: BOSUTINIB BOSUTINIB | 1件: D03252
D03252
| 2件: ABL1 ABL1, SRC 💬 | 49件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 2件: 2 2, 67 |
88 |
Botulinum toxin type A
| 8件: BOTOX BOTOX; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 13件: 2 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
89 |
Botulinum toxin type B
| 3件: Botulinum toxin type B Botulinum toxin type B; NEUROBLOC; RimabotulinumtoxinB | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 2 2, 6, 13, 51 |
90 |
Bovine type I collagen
| 1件: Bovine type I collagen Bovine type I collagen | - | - | - | 1件: 51 51 |
91 |
BPN-14770
| 0件: | - | - | - | 1件: 206 206 |
92 |
BQ-123
| 0件: | - | - | - | 1件: 17 17 |
93 |
Branaplam
| 1件: Branaplam Branaplam | - | - | - | 2件: 3 3, 8 |
94 |
Branebrutinib
| 2件: BMS-986195 BMS-986195; Branebrutinib | 1件: D11478
D11478
| 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 3件: 46 46, 49, 53 |
95 |
Brazikumab
| 1件: BRAZIKUMAB BRAZIKUMAB | 1件: D10912
D10912
| 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 |
96 |
Brensocatib
| 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
97 |
Brentuximab vedotin
| 2件: Brentuximab Brentuximab; Brentuximab Vedotin | 1件: D09587
D09587
| 10件: TNFRSF8 TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 2件: 49 49, 51 |
98 |
Brexanolone
| 1件: Allopregnanolone Allopregnanolone | 1件: D11149
D11149
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 205 205 |
99 |
Brigatinib
| 1件: Brigatinib Brigatinib | 1件: D10866
D10866
| 1件: ALK ALK 💬 | 3件: Non-small cell lung cancer Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬 | 1件: 34 34 |
100 |
Brimonidine
| 2件: Brimonidine Brimonidine; Brimonidine tartrate | 2件: D02076
D02076
,
D07540
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 90 |
101 |
Brivaracetam
| 1件: BRIVARACETAM BRIVARACETAM | 1件: D08879
D08879
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 2件: 149 149, 309 |
102 |
Broccoli
| 1件: Broccoli Broccoli | - | - | - | 3件: 36 36, 97, 299 |
103 |
Brodalumab
| 1件: Brodalumab Brodalumab | 1件: D10061
D10061
| 1件: IL17RA IL17RA 💬 | 3件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬 | 2件: 37 37, 51 |
104 |
Bromocriptine
| 1件: Bromocriptine Bromocriptine | 2件: D00780
D00780
,
D03165
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 74 |
105 |
Bryostatin 1
| 1件: Bryostatin 1 Bryostatin 1 | - | - | - | 1件: 62 62 |
106 |
BTRX-246040
| 1件: BTRX-246040 BTRX-246040 | - | - | - | 1件: 6 6 |
107 |
Bucelipase alfa
| 2件: Bucelipase alfa Bucelipase alfa; RhBSSL | - | - | - | 1件: 299 299 |
108 |
Bucillamine
| 1件: Bucillamine Bucillamine | 1件: D01809
D01809
| - | - | 1件: 46 46 |
109 |
Buckwheat
| 1件: Buckwheat Buckwheat | - | - | - | 1件: 226 226 |
110 |
Bucladesine
| 1件: Bucladesine Bucladesine | 1件: D07546
D07546
| 16件: PDE10A PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 18件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 246 246 |
111 |
Budesonide
| 4件: BUDESONIDE BUDESONIDE; Entocort; Jorveza; Symbicort | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
112 |
Bumetanide
| 1件: Bumetanide Bumetanide | 1件: D00247
D00247
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 2件: 6 6, 158 |
113 |
Bupivacaine
| 2件: Bupivacaine Bupivacaine; BUPIVACAINE HYDROCHLORIDE | 2件: D01450
D01450
,
D07552
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 8件: 46 46, 51, 53, 70, 96, 168, 226, 298 |
114 |
Buprenorphine
| 1件: Buprenorphine Buprenorphine | 2件: D00836
D00836
,
D07132
| 2件: OPRK1 OPRK1, OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 70, 298 |
115 |
Bupropion
| 2件: Bupropion Bupropion; Bupropion Hydrochloride | 3件: D00817
D00817
,
D07591
,
D07938
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
116 |
Burlulipase
| 1件: Burlulipase Burlulipase | - | - | - | 1件: 299 299 |
117 |
Burosumab
| 1件: Burosumab Burosumab | 1件: D10913
D10913
| 1件: FGF23 FGF23 💬 | 11件: Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | 1件: 238 238 |
118 |
Buspirone
| 2件: Buspirone Buspirone; Buspirone Hydrochloride | 2件: D00702
D00702
,
D07593
| 2件: DRD2 DRD2, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 51, 179 |
119 |
Busulfan
| 3件: Busilvex Busilvex; BUSULFAN; BUSULFANO | 1件: D00248
D00248
| - | - | 13件: 19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 |
120 |
Butylene glycol
| 0件: | 1件: D10695
D10695
| - | - | 2件: 28 28, 46 |
121 |
Butylphthalide
| 1件: Butylphthalide Butylphthalide | - | - | - | 4件: 2 2, 6, 18, 22 |
122 |
Butyric Acid
| 2件: Butanoic acid Butanoic acid; Butyrate | 1件: D05866
D05866
| - | - | 4件: 34 34, 51, 97, 291 |